you are here:
Success
Alert
Please select a Day.
Info
1,964.30
6.85 (0.35%)

As on 18 May, 2021 | 11:21

Trade
Day Range
1958.00
1984.90
L H
52 Week Range
1331.00
2049.00
L H
Volume
22,558
*
i

* BSE Market Depth (18 May 2021)

BUY SELL
QTY PRICE PRICE QTY
4 1962.30 1964.95 2
1 1962.15 1965.15 2
2 1962.05 1965.55 21
10 1961.90 1965.60 76
1 1961.30 1965.70 58
8687 Total Total 8366
Bid / Ask
1962.30 / 1964.95
1,965.55
5.50 (0.28%)

As on 18 May, 2021 | 11:21

Day Range
1960.80
1993.00
L H
52 Week Range
1330.00
2047.85
L H
Volume
1,888
*
i

* BSE Market Depth (18 May 2021)

BUY SELL
QTY PRICE PRICE QTY
4 1962.30 1964.95 2
1 1962.15 1965.15 2
2 1962.05 1965.55 21
10 1961.90 1965.60 76
1 1961.30 1965.70 58
8687 Total Total 8366
Bid / Ask
1962.30 / 1964.95
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open1,965.25
          Previous Close1,957.45
          UC Limit2,348.90
          LC Limit1,566.00
          Volume22,558.00
          VWAP1,968.62
          Mkt Cap (Rs. Cr.)16,997
          20D Avg Volume239,848
          20D Avg Delivery87,890
          Beta0.260.24
          Face Value2.00
          TTM EPS75.56
          TTM PE26.00
          Sector PE41.85
          Book Value Per Share375.82
          P/B5.23
          Dividend Yield0.66
          P/C22.08

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 47.79% away from 52 week low
          • 4.07% away from 52 week high
          • Outperformer - Ajanta Pharma up by 13.44% v/s NIFTY 50 up by 3.51% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          6

          indicates Average Financials

          3 year CAGR growth
          Revenue 10.7%
          NetProfit 11.7%
          OperatingProfit 14.9%
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - High in industry
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Above industry Median
          Shareholding Pattern
          • Promoters pledged 0.32% of shares in last quarter. Total pledge stands at 15.49% of promoter holdings
          • Promoters holding remains unchanged at 70.34% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 9.78% to 9.53% in Mar 2021 qtr
          • Number of MF schemes decreased from 16 to 15 in Mar 2021 qtr
          • FII/FPI have increased holdings from 7.9% to 8.37% in Mar 2021 qtr.
          • Number of FII/FPI investors decreased from 184 to 176 in Mar 2021 qtr
          • Institutional Investors have increased holdings from 20.37% to 20.99% in Mar 2021 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          News

          Forum

          Community Sentiments

          • 60% BUY
          • 20% SELL
          • 20% HOLD
          60%
          of moneycontrol users recommend buying Ajanta Pharma

          What's your call on Ajanta Pharma today?

          Read 5 investor views

          BUY SELL HOLD

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          18 Apr, 2019

          KOTAK MAHINDRA (INTERNATIONAL) LTD

          Qty 505977 Price 1033 % Traded 0.58
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RBA FINANCE AND INVEST CO

          Qty 150000 Price 397.5 % Traded 0.17
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 350000 Price 399.44 % Traded 0.40
          17 Jan, 2013

          RAMJIDAS & SONS

          Qty 150000 Price 397.5 % Traded 0.17
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 278.92 % Traded 0.08
          16 May, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 66758 Price 279.75 % Traded 0.08
          11 Apr, 2011

          CROSSEAS CAPITAL SERVICES PVT. LTD.

          Qty 114454 Price 232.14 % Traded 0.13

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          May, 17, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 130000 Price 1942.95 % Traded 0.15 Post Tnx Hold. 14.36%
          May, 14, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 240000 Price 2010.05 % Traded 0.28 Post Tnx Hold. 14.36%
          May, 14, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 275000 Price 2005 % Traded 0.32 Post Tnx Hold. 14.36%
          May, 10, 2021

          SAM SOTIRIOS GIOSKOS

          Designated Person
          Qty 3750 Price 1964.66 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 24, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 670000 Price 1778.8 % Traded 0.77 Post Tnx Hold. 14.36%
          Mar, 12, 2021

          Aayush M Agrawal, trustee Aayush Agrawal Trust

          Promoter
          Qty 35000 Price 1800.05 % Traded 0.04 Post Tnx Hold. 14.36%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Jul, 11, 2017

          Ganga Exports,a Partnership Firm

          Promoter
          Qty 2700000 Price 0 % Traded 3.07 Post Tnx Hold. 0.37%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Other
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 1.53 Post Tnx Hold. 3.07%
          Nov, 21, 2016

          Yogesh M Agrawal & Rajesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.07 Post Tnx Hold. 3.07%
          Nov, 10, 2016

          Yogesh M Agrawal

          Promoter
          Qty 2703360 Price 0 % Traded 3.08 Post Tnx Hold. 0%
          Sep, 26, 2016

          Yogesh M Agrawal

          Other
          Qty 30839779 Price 0 % Traded 35.06 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Ajanta Pharma 1964.90 0.38 17002.63 26.00 5.23 21.82 40.01 653 2,889 0.00
          Sun Pharma 693.65 0.95 166429.87 64.95 3.39 8.31 57.40 4,186 32,837 0.17
          Divis Labs 4060.00 0.41 107780.24 57.62 14.74 18.83 74.23 1,376 5,394 0.00
          Dr Reddys Labs 5272.30 0.42 87679.00 44.93 4.97 11.06 43.30 1,903 19,047 0.17
          Cipla 884.75 0.40 71352.17 29.67 4.47 13.12 47.35 2,401 19,159 0.08

          About the Company

          Ajanta Pharma Limited (APL), is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales. They cater to therapeutic areas like cardiology, ophthalmology and dermatology.They manufacture various dosage forms such as tablets, capsules, injections, ointments and powders. The companys research and development division conduct activities in three aspects namely new drug delivery system (NDDS), formulation and development and herbal/ nutraceutical.
          {"success":1,"data":{"address":{"address1":"\"Ajanta House\",","address2":"Charkop,,Kandivli (West),","city":"Mumbai","state":"Maharashtra","pincode":"400067","telephone1":"022-66061000","telephone2":"","fax1":"022-66061200","fax2":"022-66061300","email":"info@ajantapharma.com","web":"http:\/\/www.ajantapharma.com"},"management":[{"name":"Mannalal B Agrawal","designation":"Chairman"},{"name":"Madhusudan B Agrawal","designation":"Vice Chairman"},{"name":"Yogesh M Agrawal","designation":"Managing Director"},{"name":"Rajesh M Agrawal","designation":"Joint Managing Director"},{"name":"Chandrakant M Khetan","designation":"Independent Director"}],"registrars":{"name":"Link Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West)","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532331","nseId":"AJANTPHARM","series":"EQ","isinid":"INE031B01049"}}}
          • Registered Office

          • Registrars

          • Management

            • Mannalal B Agrawal

              Chairman

            • Madhusudan B Agrawal

              Vice Chairman

            • Yogesh M Agrawal

              Managing Director

            • Rajesh M Agrawal

              Joint Managing Director

            • Chandrakant M Khetan

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              532331

            • NSE:

              AJANTPHARM

            • Series

              EQ

            • ISIN

              INE031B01049

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>